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OBJECTIVEdTo assess associations of gestational diabetes, existing diabetes, and glycosuria
with adiposity and cardiometabolic risk factors in offspring at adolescence.
RESEARCH DESIGN AND METHODSdMultivariable regression analyses were con-
ducted in a prospective pregnancy cohort (n = 2,563–4,198 for different outcomes). Obstetric
data were abstracted from clinical records. Offspring outcomes were assessed at mean age 15.5
years. Comparedwith those lost to follow-up, participants included in the analysis were of higher
socioeconomic position. Outcomes included BMI, waist circumference, fat mass determined by
dual-energy X-ray absorptiometry scan, systolic and diastolic blood pressure (sBP and dBP,
respectively), fasting glucose, insulin, lipids, and C-reactive protein (CRP).
RESULTSdMaternal existing diabetes, gestational diabetes, and glycosuria were associated
with higher offspring BMI and fat mass (z scores); however, this effect was attenuated in the
confounder-adjusted model, and the CIs included the null value. Existing diabetes and gesta-
tional diabetes were associated with higher offspring fasting glucose levels (0.24mmol/L [95%CI
0.03–0.45] and 0.20 mmol/L [0.02–0.39], respectively). Glycosuria was associated with higher
fasting insulin (adjusted ratio of geometric means 1.12 [1.01–1.25]), but there were no clear
associations of existing or gestational diabetes with offspring fasting insulin. There was little
evidence of an association of maternal diabetes or glycosuria with offspring dBP, sBP, lipids, or
CRP.
CONCLUSIONSdMaternal pregnancy glycosuria, gestational diabetes, and existing diabetes
show some associations with higher offspring fasting glucose and insulin assessed in adolescence
but are not clearly associated with a wider range of cardiometabolic risk factors.
Diabetes Care 35:63–71, 2012
Detailed analyses from Pima Indianpopulations have demonstrated thatfetal exposure tomaternal diabetes in
utero increases the risk of obesity and type
2 diabetes for offspring in later life (1).
Fewer studies examine these associations
in non-Pima populations, in whom the
prevalence of obesity and diabetes is
much lower. A recent systematic review
and meta-analysis identiﬁes nine such
studies and concludes that maternal diabe-
tes is associated with increased offspring
BMI (2). The authors highlighted that
only three of the nine studies had adjusted
for maternal prepregnancy or early preg-
nancy BMI and that pooling results from
these studies after adjustment for maternal
BMI suggested that this was a major con-
founder for the association with offspring
BMI. However, there was evidence of
marked heterogeneity between results
from these three studies, potentially reﬂect-
ing the different underlying types of diabe-
tes examined and the prepubertal ages
examined (2). Furthermore, the review
does not include a recently published
very large sibling study in Swedish men
that similar to studies in the Pima, supports
an intrauterine mechanism linking mater-
nal diabetes in pregnancy with offspring
BMI that is not confounded by maternal
early pregnancy BMI (3). In that study,
mean BMI at age 18 years of younger broth-
ers born after their mother was diagnosed
with diabetes in pregnancy was greater
than their older brothers’ mean BMI who
were born before this diagnosis (3). It is
notable that to date, few studies have ex-
amined associations with other offspring
cardiometabolic risk factors and whether
associations are mediated by the associa-
tions with offspring adiposity.
The aim of this study was to assess the
associations between gestational diabetes,
existing diabetes, glycosuria, adiposity,
and a range of cardiometabolic risk factors
(including measures of glucose and insulin
metabolism) in offspring at age 15.5 years
and to examinewhether any associations are
mediated by excess offspring adiposity. This
article adds to a previous published study
from the same cohort in which we found
that gestational diabetes and glycosuriawere
associated with greater offspring BMI, waist
circumference, and fat mass assessed when
the offspring were aged 9–11 years but in
which we were unable to assess associations
with other cardiometabolic risk factors be-
cause of lack of relevant data at that age (4).
RESEARCH DESIGN AND
METHODSdThe Avon Longitudinal
Study of Parents and Children (ALSPAC)
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O R I G I N A L A R T I C L E
is a prospective, population-based birth
cohort study. In total, 14,541 pregnant
women with expected dates of delivery
between 1 April 1991 and 31 December
1992 were recruited (5), and there were
13,617 singleton live births who sur-
vived to 1 year. Data on existing and ges-
tational diabetes status were available for
12,440 mother-offspring pairs; of these,
9,247 offspring (those who were still
alive and engaged with the study) were
invited to the follow-up assessment
when they were mean age 15.5 years
and 5,038 attended. Figure 1 shows the
number of participants available for each
analysis.
Ethics approval was obtained from
the ALSPAC Law and Ethics Committee
and the U.K. National Health Service
Local Research Ethics Committee. Written
informed consent was obtained from
parents/guardians providing consent for
offspring up to age 16 years, with offspring
providing consent thereafter.
Assessment of maternal diabetes
and glycosuria
Information on existing maternal dia-
betes and past history of gestational di-
abetes were collected by questionnaire
from women at the time of recruitment.
A standard protocol was used by research
midwives to obtain information on gesta-
tional diabetes and glycosuria (recorded as
none, trace, +, ++, and +++ or more) for
the index pregnancy from the woman’s
antenatal and postnatal medical records.
The practice in the U.K. at the time was
for all women to be offered urine tests for
glycosuria at each antenatal clinic visit.
Universal screening of women with a
random or fasting blood glucose level or
with an oral glucose tolerance test was not
undertaken, and diagnostic tests for gesta-
tional diabetes will have been undertaken
only in women with established risk fac-
tors (obesity, family history of diabetes
and previous history of gestational diabe-
tes or macrosomic birth, and south Asian
ethnicity) or glycosuria. Glycosuria in our
study was deﬁned as a record of at least ++
(equal to 13.9 mmol/L or 250 mg/100 mL)
on at least two occasions at any time during
the pregnancy in the absence of existing
diabetes and gestational diabetes. Because
some level of glycosuria is common in
pregnancy as a result of increased glomer-
ular ﬁltration rate (6), 250 mg/100 mL
is the threshold that has generally been
used for indicating the need for further
Figure 1dParticipation ﬂow diagram through the study and the numbers included in each of the main analyses.
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testing to diagnose gestational diabetes
(7). Women were categorized into one of
four mutually exclusive categories of no
existing diabetes or glycosuria (healthy),
existing diabetes, gestational diabetes, and
glycosuria.
Assessment of offspring adiposity
and cardiometabolic risk factors
Offspring’s weight and height were mea-
sured in light clothing and without shoes
and used to calculate BMI. Weight was
measured to the nearest 0.1 kg using Tanita
scales. Height was measured to the nearest
0.1 cm using a Harpenden stadiometer.
Waist circumference was measured to the
nearest 1 mm at the midpoint between the
lower ribs and the pelvic bone using a ﬂex-
ible tape. A narrow fan beam densitometer
(Lunar Prodigy; GE Healthcare Lunar Ltd.,
Cambridge, U.K.) was used to perform a
whole-body dual-energy X-ray absorpti-
ometry scan in which bone content and
lean and fat mass were measured. Age-
and sex-standardized z scores were cal-
culated for BMI, waist circumference, and
fat mass.
Overweight or obesity was deﬁned
using BMI and criteria deﬁned by the
International Obesity Task Force (8).
Central obesity was deﬁned as waist cir-
cumference greater than the 90th centile
(9) of U.K. age- and sex-speciﬁc centile
curves (10).
Blood pressure was measured with
a Dinamap 9302 Vital Signs Monitor
(Morton Medical, London, U.K.) with the
correct cuff size. Two readings of systolic
and diastolic blood pressure (sBP and
dBP, respectively) were recorded with the
participant at rest and their arm supported,
and the mean of the two measures was
used.
Fasting venous blood samples were
taken, and samples were immediately spun
and frozen at 2808C. Measurements were
assayed 3–9 months after samples were
taken, with no previous freeze-thaw cycles.
Plasma lipid concentrations (total choles-
terol, triglycerides, and HDL cholesterol
[HDLc]) were measured by modiﬁcation
of the standard Lipid Research Clinical
Protocol by using enzymatic reagents for
lipid determination. Non–HDLc was cal-
culated as total cholesterol minus HDLc.
LDL cholesterol (LDLc) was calculated
from directly measured lipid levels using
Friedewald formula. Insulin was measured
with anELISA (Mercodia,Uppsala, Sweden)
that does not cross-react with proinsulin.
The recent consensus statement on insu-
lin resistance in children suggests that
homeostasis model assessment of insulin
resistance is so highly correlated with fast-
ing insulin (r = 0.98 in our sample) that it
does not provide any added value to using
fasting levels (11). Our ﬁndings were iden-
tical whether we used fasting insulin or
homeostasis model assessment of insulin
resistance, and we therefore present only
those for fasting insulin (12). Plasma glu-
cose was measured with an automated
assay. C-reactive protein (CRP) was mea-
sured by automated particle-enhanced
immunoturbidimetric assay (Roche,
Welwyn Garden City, U.K.).
Assessment of covariables
Mode of delivery (caesarean section), ges-
tational age, birth weight, and offspring’s
sex were extracted from medical records.
Parity, parental occupation, and maternal
prepregnancy weight and height were ob-
tained from questionnaires completed by
the mothers at recruitment in early preg-
nancy. Information on smoking during
pregnancy was obtained from question-
naires completed by mothers throughout
pregnancy and was categorized as never
smoked during pregnancy or smoked
during ﬁrst trimester only/throughout
pregnancy. Highest parental occupation
was used to allocate children to family
social class groups (classes I [professional/
management] to V [unskilled manual
workers], using the 1991 British Ofﬁce
of Population and Census Statistics classi-
ﬁcation). Maternal-reported height and
prepregnancy weight were used to calcu-
late maternal prepregnancy BMI; reported
prepregnancy weight correlated highly
(Pearson correlation coefﬁcient = 0.95)
with measured weight at the ﬁrst antenatal
clinic.
Statistical analysis
All analysis was conducted using Stata
version 11.0 MP2 (Stata Inc., College
Station, TX). Triglycerides, insulin, and
CRP were positively (right) skewed, but
with a natural log transformation, they
were approximately normally distributed.
For these variables, we use geometric
means or medians to describe them and
natural logged values in multivariable
models. In multivariable models with
these outcomes, the resulting coefﬁcients
were exponentiated (back transformed) so
that the results are then interpreted as the
ratio of geometric means of the outcome
comparing each exposure to the category
of healthy women. Differences in distri-
butions of participant characteristics (off-
spring outcomes and maternal/family
covariables) in relation to maternal diabe-
tes or glycosuria status were tested using
x2 tests for categorical variables and t tests
or F tests for continuous variables. These
analyses tested for the null hypothesis
of no difference between the four expo-
sure groups (i.e., with 3 df) so that there
was no assumption of a linear trend across
the exposure categories of healthy, exist-
ing diabetes, gestational diabetes, and
glycosuria.
A series of multivariable linear regres-
sion models were conducted to examine
the association of maternal diabetes or gly-
cosuria with offspring outcomes and to
explore the impact of adjustment for po-
tential confounding and mediating char-
acteristics on these associations. For each
outcome, we included in the multivariable
analyses only participants who had com-
plete data on all variables used in any
model. Therefore, numbers vary between
each outcome but are the same across
models for each outcome. In the basic
model (model 1), we controlled for off-
spring age at outcome assessment and sex,
and in the models with fat mass as the
outcome, offspring’s height and height-
squared at the time of this assessment. In
model 2, we adjusted for possible con-
founding by maternal age, parity, social
class, and smoking in pregnancy. We
then adjusted for possible mediation by
birth weight, gestational age, and mode
of delivery (model 3). In analyses with car-
diometabolic risk factors, we also exam-
ined whether associations were mediated
by the association of maternal diabetes or
glycosuria with offspring adiposity (model
4). In these models (model 4), we present
results after adjustment for directly as-
sessed fat mass, but adjusting instead for
waist circumference or BMI produced
identical results. In sensitivity analyses,
we examined whether adjustment for the
number of urine tests completed altered
the associations of glycosuria with out-
comes.
Associations did not differ for males
and females, and there was no statistical
evidence of interaction with sex (all P
values for interaction $0.1). Therefore,
all results are presented with males and
females combined.
Dealing with missing data
Of the 5,038 eligible participants who
attended the 15.5-year follow-up assess-
ment, the numbers with each outcome
varied (Fig. 1), and there were missing
data on covariables. The numbers in-
cluded in the main multivariable analyses
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are those with complete data on exposure,
outcome, and all covariables included in
any model for each outcome (this varies
between 2,563 and 4,198). To examine
whether missing data on covariables might
have introduced selection bias, we also ex-
amined the basic age- and sex-adjusted as-
sociations in those with maximal data for
each outcome and compared these results
with those in the subgroups with complete
data.
RESULTSdOf the 12,440 women who
had a singleton live birth and valid ob-
stetric data, the 5,038 whose offspring
attended the follow-up assessment had
similar prevalence of diabetes/glycosuria
as the 7,402 who did not attend the
follow-up clinic; however, those women
whose offspring did not attend were
younger and were more likely to be from
manual social classes, to smoke during
pregnancy, and to have had $3 previous
pregnancies, and their offspring had lower
birth weights (Supplementary Table 1).
Table 1 shows the distributions of off-
spring outcomes and other maternal and
family characteristics by maternal diabetes
or glycosuria status. Maternal prepreg-
nancy BMI varied by maternal diabetes
or glycosuria status, withmothers who de-
veloped gestational diabetes having the
highest prepregnancy BMI and mothers
who were categorized as healthy (no ex-
isting diabetes, gestational diabetes, or
glycosuria) having the lowest prepreg-
nancy BMI. Proportion of caesarean sec-
tions also varied across the four groups,
with the existing diabetes and gestational
diabetes groups having the highest propor-
tion of caesarean sections. Birthweight (age-
and sex-standardized z scores) and fat mass
also varied by maternal diabetes or glycos-
uria status, and the highest birth weight was
for mothers with gestational diabetes.
Table 2 shows the multivariable asso-
ciations betweenmaternal diabetes or gly-
cosuria status and offspring adiposity at
mean age 15.5 years. Maternal existing di-
abetes, gestational diabetes, and glycosuria
were associated with higher BMI and fat
mass (z scores) in the simple model unad-
justed for confounders and mediators
(model 1); however, this effect was attenu-
ated and the CIs included the null value for
the fully adjusted model. Gestational dia-
betes was associated with higher mean
waist circumference z scores in the simple
unadjusted model, but this relation was at-
tenuated in the fully adjusted model. For
overweight/obesity status and central obe-
sity, theCIs for the estimateswerewide and
included the null value.
Table 3 shows the multivariable asso-
ciations of maternal diabetes or glycosuria
with offspring cardiometabolic risk factors.
Existing diabetes and gestational diabetes
were associated with higher offspring glu-
cose levels, and adjustment for potential
confounding factors and mediation by
birth size or later adiposity did not notably
alter this association. Maternal glycosuria













Head of household manual class,
n (%) 4,750 594 (13.0) 3 (13.0) 5 (19.2) 21 (14.4) 0.99
Maternal age, mean (SD) 5,038 29.2 (4.57) 29.3 (3.17) 30.3 (4.53) 29.2 (4.07) 0.66
Maternal prepregnancy BMI,
mean (SD) 4,711 22.8 (3.60) 24.9 (3.86) 27.2 (6.66) 23.8 (4.55) ,0.001
Mother smoked during pregnancy,
n (%) 4,976 783 (16.4) 2 (8.70) 2 (7.41) 26 (17.1) 0.37
Parity (3 or more), n (%) 4,903 212 (4.48) 0 3 (11.5) 8 (5.37) 0.31
Caesarean section, n (%) 4,971 482 (10.1) 13 (56.5) 9 (34.6) 16 (10.4) ,0.001
Gestational age, mean (SD) 5,038 39.4 (1.85) 37.5 (1.86) 38.6 (1.48) 39.7 (1.63) ,0.001
Age (months), mean (SD) 5,038 185.5 (4.05) 186.0 (3.01) 185.5 (2.95) 185.9 (4.74) 0.73
Birth weight (z scores), mean (SD) 4,972 0.038 (0.97) 0.28 (1.32) 1.45 (1.28) 0.18 (1.04) ,0.001
Number of urine tests, median (IQR) 5,038 12 (9–14) 14 (12–21) 15 (12–17) 14 (12–16) ,0.001
Outcome
Fat mass (z scores), mean (SD) 4,960 20.02 (0.97) 0.34 (1.43) 0.38 (1.11) 0.10 (1.17) 0.02
BMI (z scores), mean (SD) 4,960 20.02 (0.97) 0.34 (1.43) 0.37 (1.11) 0.10 (1.17) 0.02
Overweight/obese, n (%) 4,960 782 (16.4) 6 (26.1) 8 (29.6) 33 (22.2) 0.06
Waist circumference (z scores),
mean (SD) 4,114 20.01 (0.98) 0.19 (1.35) 0.53 (1.15) 20.06 (1.01) 0.06
Triglycerides (mmol/L), geometric
mean (SD) 3,181 0.77 (0.38) 0.75 (0.20) 0.64 (0.30) 0.76 (0.36) 0.23
HDLc (mmol/L), mean (SD) 3,181 1.28 (0.29) 1.36 (0.23) 1.37 (0.31) 1.30 (0.29) 0.45
Non–HDLc (mmol/L), mean (SD) 3,181 2.46 (0.62) 2.60 (0.70) 2.55 (0.56) 2.56 (0.63) 0.33
LDLc (mmol/L), mean (SD) 3,181 2.08 (0.55) 2.25 (0.67) 2.25 (0.48) 2.19 (0.57) 0.11
Glucose (mmol/L), mean (SD) 3,181 5.21 (0.38) 5.45 (0.37) 5.40 (0.47) 5.23 (0.46) 0.03
Insulin (IU/L), geometric mean (SD) 3,177 9.03 (0.49) 9.58 (0.43) 8.50 (0.51) 10.3 (0.52) 0.06
CRP (mg/L), geometric mean (SD) 3,181 0.49 (1.11) 0.28 (0.59) 0.58 (1.07) 0.48 (1.09) 0.27
sBP (mmHg), mean (SD) 4,678 123.1 (10.8) 123.6 (9.43) 123.8 (10.3) 121.7 (11.1) 0.44
dBP (mmHg), mean (SD) 4,678 67.6 (8.76) 67.5 (6.59) 69.4 (7.48) 67.4 (8.58) 0.76
IQR, interquartile range.
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was not associated with offspring glucose
levels. Maternal glycosuria, but not existing
or gestational diabetes, was associated with
higher fasting insulin levels in offspring,
and this associationwasnotmarkedly altered
by adjustment for potential confounding or
mediating characteristics. Maternal diabe-
tes or glycosuria were not associated with
other offspring cardiometabolic risk fac-
tors (sBP, dBP, HDLc, non–HDLc, LDLc,
triglycerides, or CRP). Additional adjust-
ment for the number of urine tests did not
change any associations presented in
Tables 2 and 3.
There were no notable differences in
associations between maternal diabetes
and glycosuria with outcomes when com-
paring age- and sex-adjusted models
(model 1) for all participants with these
data (range 3,177–4,960) to results presen-
ted in Tables 2 and 3.
CONCLUSIONSdIn this prospective
birth cohort study, we have found that at
mean age 15.5 years, maternal gestational
diabetes and glycosuria were associated
with higher mean fat mass and BMI z
scores in simple unadjusted analyses,
with the association attenuating somewhat
in multivariable models. Offspring of
mothers who had existing or gestational
diabetes during their pregnancy had
higher fasting glucose, but this was not
accompanied by an increase in fasting in-
sulin. In contrast, offspring of mothers
who experienced glycosuria in pregnancy
had higher fasting insulin. We found little
evidence of associations between maternal
diabetes or glycosuria and a wider range of
cardiometabolic risk factors beyond glu-
cose and insulin (i.e., no associations with
dBP, sBP, lipids, or CRP).
In a previously published study from
the same cohort, we demonstrated that
gestational diabetes and glycosuria were
associated with greater offspring BMI,
waist circumference, and fat mass assessed
when the offspring were aged 9–11 years
and that although associations attenuated
with adjustment for potential confound-
ing factors, including maternal early preg-
nancy BMI, the positive associations
remained (4). It is notable that the point
estimates for all models in the current
analyses, conducted using data obtained
when participants were on average 5 years
older (now adolescents), are nearly identi-
cal to those in that earlier publication.
Thus, although the adjusted (including
for maternal BMI) associations in this cur-
rent study are consistent with the null, it
would be incorrect to conclude that any
effect of exposure to maternal dysglycemia
in utero declines with age. The magnitude
of the association appears stable between
childhood and adolescence, but in the cur-
rent study, we have less statistical power
as a result of smaller sample size (gesta-
tional diabetes and glycosuria, n = 23 and
123, respectively) compared with the pre-
vious study for outcomes at age 9–11 years
(gestational diabetes and glycosuria, n = 40
and 232, respectively). Although a recent
meta-analysis concludes that in European
populations, there was no association be-
tween pregnancy diabetes and offspring
BMI once maternal BMI was taken into ac-
count, that conclusion was based on pool-
ing data from just three studies that
together included only 244 offspring of
mothers with diabetes and were clinically










BMI (z scores sex and age adjusted)
(n = 4,198)
Model 1 0 0.39 (20.01 to 0.80) 0.30 (20.10 to 0.69) 0.10 (20.07 to 0.27)
Model 2 0 0.21 (20.16 to 0.59) 20.15 (20.52 to 0.22) 0.01 (20.15 to 0.17)
Model 3 0 0.19 (20.18 to 0.57) 20.26 (20.63 to 0.11) 0.004 (20.16 to 0.17)
Obese/overweight, odds ratios
(95% CIs) (n = 4,198)
Model 1 1 4.59 (1.34–15.7) 2.77 (0.64–11.9) 1.75 (0.80–3.84)
Model 2 1 3.54 (0.98–12.8) 0.68 (0.13–3.58) 1.31 (0.55–3.10)
Model 3 1 3.30 (0.86–12.7) 0.54 (0.10–3.03) 1.30 (0.54–3.10)
Waist circumference (z scores sex
and age adjusted) (n = 3,498)
Model 1 0 0.22 (20.23 to 0.67) 0.50 (0.03–0.96) 20.08 (20.27 to 0.12)
Model 2 0 0.14 (20.29 to 0.58) 0.16 (20.29 to 0.61) 20.12 (20.31 to 0.06)
Model 3 0 0.13 (20.31 to 0.56) 0.04 (20.41 to 0.49) 20.11 (20.02 to 0.00)
Central obesity, odds ratios
(95% CIs) (n = 3,498)
Model 1 1 1.07 (0.42–2.70) 1.53 (0.58–4.02) 1.27 (0.86–1.84)
Model 2 1 0.99 (0.39–2.52) 1.09 (0.40–2.98) 1.21 (0.82–1.81)
Model 3 1 1.03 (0.39–2.69) 0.90 (0.32–2.52) 1.23 (0.83–1.84)
Fat mass (z scores sex and age
adjusted) (n = 4,035)
Model 1 0 0.38 (20.03 to 0.79) 0.36 (20.04 to 0.75) 0.20 (0.03–0.38)
Model 2 0 0.23 (20.15 to 0.62) 20.06 (20.43 to 0.31) 0.11 (20.06 to 0.27)
Model 3 0 0.23 (20.16 to 0.62) 20.14 (20.51 to 0.24) 0.10 (20.06 to 0.27)
Data are mean differences (95% CIs) unless otherwise noted. Model 1 (simple), adjusted for sex and age by outcome. For fat mass outcome, additional adjustment for
height and height squared. Model 2 (confounder adjusted), as model 1 plus maternal age, manual social class, maternal smoking during pregnancy, parity, and
maternal prepregnancy BMI. Model 3 (confounder and mediator adjusted), as model 2 plus gestational age, birth weight, and mode of delivery. xReference group.
†Number of observations for each outcome.
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dBP (n = 3,917)
Model 1 0 20.52 (24.27 to 3.23) 1.68 (21.99 to 5.34) 0.53 (21.11 to 2.17)
Model 2 0 20.48 (24.23 to 3.28) 1.96 (21.72 to 5.64) 0.59 (21.05 to 2.23)
Model 3 0 20.41 (24.19 to 3.38) 1.70 (22.01 to 5.41) 0.57 (21.07 to 2.21)
Model 4 0 20.55 (24.30 to 3.20) 1.95 (21.72 to 5.62) 0.54 (21.09 to 2.16)
sBP (n = 3,917)
Model 1 0 1.08 (23.41 to 5.58) 20.79 (25.18 to 3.61) 20.87 (22.83 to 1.09)
Model 2 0 0.69 (23.80 to 5.19) 21.67 (26.08 to 2.74) 21.12 (23.08 to 0.85)
Model 3 0 20.21 (24.73 to 4.31) 21.39 (25.82 to 3.03) 21.02 (22.98 to 0.94)
Model 4 0 20.49 (24.88 to 3.90) 20.78 (25.07 to 3.52) 21.25 (23.15 to 0.65)
Triglycerides, ratio
of geometric means
(95% CIs) (n = 2,567)
Model 1 1 0.99 (0.81–1.23) 0.82 (0.69–0.99) 0.96 (0.88–1.05)
Model 2 1 0.99 (0.81–1.23) 0.83 (0.69–1.00) 0.96 (0.88–1.04)
Model 3 1 1.01 (0.82–1.24) 0.85 (0.70–1.03) 0.96 (0.88–1.04)
Model 4 1 1.02 (0.83–1.25) 0.89 (0.74–1.07) 0.95 (0.88–1.03)
HDLc (n = 2,567)
Model 1 0 0.09 (20.07 to 0.25) 0.15 (0.00–0.29) 0.00 (20.07 to 0.06)
Model 2 0 0.09 (20.7 to 0.25) 0.17 (0.03–0.32) 0.01 (20.06 to 0.07)
Model 3 0 0.08 (20.08 to 0.24) 0.17 (0.03–0.32) 0.01 (20.06 to 0.07)
Model 4 0 0.06 (20.10 to 0.22) 0.13 (20.01 to 0.27) 0.01 (20.05 to 0.08)
Non–HDLc (n = 2,567)
Model 1 0 0.23 (20.10 to 0.57) 0.12 (20.18 to 0.42) 0.06 (20.08 to 0.19)
Model 2 0 0.22 (20.11 to 0.56) 0.11 (20.19 to 0.42) 0.05 (20.09 to 0.18)
Model 3 0 0.20 (0.13–0.54) 0.11 (20.19 to 0.42) 0.05 (20.09 to 0.18)
Model 4 0 0.21 (20.12 to 0.54) 0.17 (20.12 to 0.47) 0.04 (20.09 to 0.17)
LDLc (n = 2,567)
Model 1 0 0.25 (20.05 to 0.55) 0.20 (20.07 to 0.46) 0.07 (20.05 to 0.19)
Model 2 0 0.25 (20.05 to 0.55) 0.18 (20.09 to 0.45) 0.06 (20.06 to 0.19)
Model 3 0 0.25 (20.05 to 0.55) 0.18 (20.09 to 0.45) 0.06 (20.06 to 0.19)
Model 4 0 0.22 (20.08 to 0.52) 0.21 (20.05 to 0.48) 0.06 (20.06 to 0.18)
Glucose (n = 2,567)
Model 1 0 0.25 (0.04–0.45) 0.21 (0.02–0.39) 0.04 (20.04 to 0.13)
Model 2 0 0.25 (0.04–0.45) 0.19 (0.01–0.38) 0.03 (20.05 to 0.12)
Model 3 0 0.24 (0.03–0.44) 0.19 (0.00–0.38) 0.03 (20.05 to 0.11)
Model 4 0 0.24 (0.03–0.45) 0.20 (0.02–0.39) 0.03 (20.05 to 0.11)
Insulin, ratio of
geometric means
(95% CIs) (n = 2,563)
Model 1 1 1.09 (0.84–1.41) 1.01 (0.80–1.28) 1.15 (1.03–1.28)
Model 2 1 1.08 (0.83–1.39) 0.94 (0.74–1.18) 1.12 (1.01–1.25)
Model 3 1 1.07 (0.83–1.39) 0.94 (0.75–1.19) 1.12 (1.01–1.24)
Model 4 1 1.13 (0.89–1.43) 1.05 (0.84–1.30) 1.10 (1.00–1.22)
CRP, ratio of
geometric means
(95% CIs) (n = 2,567)
Model 1 1 0.58 (0.31–1.08) 0.95 (0.54–1.65) 0.95 (0.77–1.27)
Model 2 1 0.57 (0.31–1.06) 0.84 (0.48–1.46) 0.95 (0.74–1.22)
Model 3 1 0.56 (0.30–1.05) 0.84 (0.48–1.48) 0.95 (0.74–1.22)
Model 4 1 0.60 (0.34–1.09) 1.02 (0.60–1.74) 0.92 (0.73–1.17)
Data aremean differences (95%CIs) unless otherwise noted.Model 1 (simple), adjusted for sex and age. Model 2 (confounder adjusted), as model 1 plusmaternal age,
manual social class, maternal smoking during pregnancy, parity, andmaternal prepregnancy BMI. Model 3 (mediator adjusted), as model 2 plus gestational age, birth
weight, and mode of delivery. Model 4 (mediator adjusted including adiposity), as model 3 plus fat mass, height, and height squared. xReference group. †Number of
observations for each outcome.
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heterogeneous with mothers with either
type 1 diabetes, gestational diabetes, or a
composite of both (2). A positive associa-
tion of maternal diabetes with BMI in ado-
lescence that is independent of maternal
BMI is supported by results from a recently
published large prospective cohort of
280,866 men aged 18 years (n = 1,475
mothers with diabetes in pregnancy) that
usedwithin-sibling comparisons to control
for ﬁxed-family characteristics (3).
In our population, frank maternal
diabetes (existing or gestational) was as-
sociated with offspring fasting glucose,
whereas glycosuria (a marker of potential
gestational hyperglycemia) was associ-
ated with offspring fasting insulin but
not glucose. It is possible that the former
reﬂects inherited genetic variants associ-
ated with higher glucose as well as in-
trauterine mechanisms. By contrast, the
glycosuria association may be driven
solely by intrauterine mechanismsdby
higher maternal glucose inﬂuencing fetal
insulin secretion that persists after birth.
However, given the issues regarding sen-
sitivity of glycosuria as a marker of hyper-
glycemia in pregnancy (see below) and
the small numbers in this study, these ap-
parent differences may be chance ﬁndings
and need further replication in larger
studies with continuous measurements
of fasting (and postload) glucose and in-
sulin in pregnancy.
Our ﬁndings regarding measures of
glucose metabolism are consistent with
the small number of studies that examine
these associations in non-Pima popula-
tions. Clausen et al. (13) reported higher
fasting glucose levels in offspring of
gestational diabetic mothers (n = 168)
compared with healthy control subjects
(n = 128), and three studies report higher
levels of insulin resistance in the off-
spring of mothers with gestational dia-
betes compared with those without, with
the number with gestational diabetes in
these studies varying from 68 to 232
(14–16). In one study, there was no strong
evidence of an association of gestational
diabetes (n = 95) with offspring fasting
glucose, but positive associations with
fasting insulin and insulin resistance
were observed (17).
There may be a number of mecha-
nisms by which gestational glucose status
affects offspring fasting glucose and in-
sulin in later life. First, genetic variation
associated with type 2 diabetes and/or
variation in fasting glucose and insulin
could explain the associations that we have
observed. Evidence from Pima Indians
(sibling and parental comparisons) sug-
gests that genetic inheritance does not
fully explain the associations of maternal
pregnancy diabetes and offspring fasting
glucose/diabetes in that population (18),
but we are unable to undertake such fa-
milial studies in our cohort owing to lack
of information on diabetes in fathers or
outcomes in siblings. In addition to the
Pima family studies, there is a large body
of evidence from different populations
showing that maternal type 2 diabetes
(not speciﬁcally in pregnancy) is more
strongly associated with offspring type 2
diabetes risk than paternal type 2 diabetes
(19–21). Possible explanations for this in-
clude speciﬁc intrauterine mechanisms,
with women who are prone to type 2 di-
abetes likely to have higher glucose levels
in pregnancy that could program off-
spring to increased risk of type 2 diabetes
later in life, and others such as differences
in transmission of diabetes risk factors
(i.e., mothers possibly having more im-
pact on offspring diet and physical ac-
tivity behaviors than fathers), effects of
mitochondrial DNA on type 2 diabetes,
and genetic imprinting (22).
Second, maternal diabetes during
pregnancy is known to result in greater
fat mass at birth, with the suggestion that
insulin resistance might be present at
birth (23). This could persist into later
life of the offspring and result in increased
levels of glucose and insulin. Third,
shared familial lifestyles or genetic varia-
tion related to greater adiposity could ex-
plain the associations that we have
observed because greater adiposity is an
important risk factor for gestational diabe-
tes (24) and variation in fasting glucose
and insulin. However, in our study, we
have shown that offspring adiposity
(whether assessed by BMI, waist circum-
ference, or directly assessed fat mass) does
not appear to mediate the associations
with offspring glucose and insulin that
we have observed.
Lastly, intrauterine mechanisms
might explain these associations. Expo-
sure to greater maternal circulating levels
of glucose in pregnancy results in in-
creased fetal insulin secretion in utero
(11), and this greater activity of the fetal
pancreas may have lasting effects on off-
spring glucose/insulin metabolism
throughout their life. A recent sibling
study in a non-Pima population sug-
gests an intrauterine mechanism for
the association with offspring greater
adiposity (2), and Pima sibling and pa-
rental comparison studies also support
this for fasting glucose and insulin (18),
but we are unaware of any non-Pima
studies that have relevant data, includ-
ing fasting glucose and insulin in off-
spring siblings, and sufﬁcient statistical
power to determine that this is the case
in these populations.
Strengths and limitations
The main strength of this study is that we
were able to examine associations of
maternal diabetes/glycosuria with a range
of offspring cardiometabolic risk factors,
which have rarely been examined before.
The main limitation is the small number
of participants with gestational diabetes
and the possibility that the lack of uni-
versal screening with a blood glucose test
at the time the mothers in this study were
pregnant may mean that some women
with gestational diabetes were not identi-
ﬁed as such. This is supported by the
relatively low prevalence of gestational
diabetes in this cohort (0.5%) compared
with prevalence of 1.2% in a study pop-
ulation of U.K. pregnant women who
were also assessed in the early 1990s but
who underwent screening using oral glu-
cose tolerance tests as part of a research
study (25). However, comparing our
study with that study is complicated by
the fact that it was conducted in a rela-
tively deprived, multiethnic group of
women who would be expected to have
higher rates of gestational diabetes than
our population who are by comparison
more afﬂuent and largely (98%) of white
British ethnicity. It is notable that the
prevalence of preexisting diabetes is
in line with the expected prevalence of
1 in 250. It is possible that women deﬁned
as having glycosuria in this study
included a mixture of women with high
circulating glucose levels (but below the
threshold that would be used to deﬁne
gestational diabetes) and also women
with undiagnosed gestational diabetes.
Any such misclassiﬁcation would be
nondifferential with respect to the out-
comes that we have assessed because
clinicians providing antenatal care could
not possibly know what the measures of
fat mass or blood glucose, insulin, and
lipids of offspring would be 15–16 years
later.
Despite these issues, we have previ-
ously shown that glycosuria is related to
macrosomia in this cohort, giving face
validity to its use as an assessment of
hyperglycemia (4).
Loss to follow-up in our study is
consistent with other prospective cohort
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studies, and although it can affect statis-
tical power, it is unlikely to have impor-
tantly biased the association results. This
is because loss to follow-up is likely to be
nondifferential with respect to outcomes
(participants would not be aware of their
fasting glucose, insulin, or lipid levels)
and because to importantly bias the ﬁnd-
ings, we would have to assume that the
associations we have foundwere null or in
the opposite direction (i.e., maternal di-
abetes in pregnancy or glycosuria being
associated with lower offspring glucose
and insulin) in those individuals lost to
follow-up.
Our results suggest that maternal
diabetes in pregnancy (existing or gesta-
tional) is associated with greater offspring
fasting glucose in adolescence and ma-
ternal hyperglycemia (as indicated by
glycosuria) is associated with greater off-
spring fasting insulin in adolescence.
These associations do not appear to be
mediated by birth weight or offspring
adiposity at the time of glucose and
insulin assessment. Results from this
study add to the relatively small body of
evidence to date suggesting that maternal
diabetes or hyperglycemia in pregnancy
are related to offspring diabetes risk
factors. However, further large studies
are required to replicate these ﬁndings,
andmethods such as sibling comparisons
and long-term follow-up of trials assessing
the effectiveness of treatments for gesta-
tional diabetes/hyperglycemia are needed
to determine whether these associations
are at least in part driven by intrauterine
mechanisms or are fully explained by
shared familial genetic or environmental
characteristics. Of note, our study suggests
that beyond associations with adiposity
and fasting glucose and insulin, maternal
hyperglycemia/diabetes in pregnancy is
not associated with a broader range of
cardiometabolic risk factors.
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